Home LiteratureArticle Details
PMID: 21826372 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Retroviral insertional mutagenesis can contribute to immortalization of mature T lymphocytes.

Molecular medicine (Cambridge, Mass.) ·Vol. 17 ·No. 11-12 ·2011-00-00 ·Pages 1223-32

Newrzela S, Cornils K, Heinrich T, Schläger J, Yi JH, Lysenko O, Kimpel J, Fehse B, von Laer D

Abstract

Several cases of T-cell leukemia caused by gammaretroviral insertional mutagenesis in children treated for x-linked severe combined immunodeficiency (SCID) by transplantation of autologous gene-modified stem cells were reported. In a comparative analysis, we recently showed that mature T cells, on the contrary, are highly resistant to transformation by gammaretroviral gene transfer. In the present study, we observed immortalization of a single T-cell clone in vitro after gammaretroviral transduction of the T-cell protooncogene LMO2. This clone was CD4/CD8 double-negative, but expressed a single rearranged T-cell receptor. The clone was able to overgrow nonmanipulated competitor T-cell populations in vitro, but no tumor formation was observed after transplantation into Rag-1 deficient recipients. The retroviral integration site (RIS) was found to be near the IL2RA and IL15RA genes. As a consequence, both receptors were constitutively upregulated on the RNA and protein level and the immortalized cell clone was highly IL-2 dependent. Ectopic expression of both, the IL2RA chain and LMO2, induced long-term growth in cultured primary T cells. This study demonstrates that insertional mutagenesis can contribute to immortalization of mature T cells, although this is a rare event. Furthermore, the results show that signaling of the IL-2 receptor and the protooncogene LMO2 can act synergistically in maligniant transformation of mature T lymphocytes.

MeSH Terms
Adaptor Proteins, Signal Transducing/metabolism Animals Biomarkers Cell Differentiation/drug effects,immunology Cell Line, Transformed Cell Proliferation/drug effects Clone Cells Genetic Vectors/genetics Humans Interleukin-2/pharmacology LIM Domain Proteins/metabolism Mice Mice, Inbred C57BL Mutagenesis, Insertional/methods Phenotype Receptors, Antigen, T-Cell/metabolism Receptors, Interleukin-15/metabolism Receptors, Interleukin-2/metabolism Retroviridae/drug effects,genetics T-Lymphocytes/cytology,drug effects,immunology Transduction, Genetic Virus Integration/drug effects
Chemicals
Adaptor Proteins, Signal Transducing Biomarkers Interleukin-2 LIM Domain Proteins Lmo2 protein, mouse Receptors, Antigen, T-Cell Receptors, Interleukin-15 Receptors, Interleukin-2
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Newrzela Sebastian
Senckenberg Institute of Pathology, Goethe-University Hospital Frankfurt, Frankfurt am Main, Germany.
Cornils Kerstin
Heinrich Tim
Schläger Julia
Yi Ji-Hee
Lysenko Olga
Kimpel Janine
Fehse Boris
von Laer Dorothee
References (39)
39 references, click to expand
  1. Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.
    Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1457-62 PMID: 16432223
  2. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma.
    Nat Med. 2010 May;16(5):571-9, 1p following 579 PMID: 20436485
  3. Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.
    Blood. 2000 Aug 1;96(3):785-93 PMID: 10910888
  4. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
    Mol Ther. 2004 Nov;10(5):874-81 PMID: 15509505
  5. Peaceful coexistence or clonal dominance?
    Blood. 2009 Oct 22;114(17):3507-8 PMID: 19850747
  6. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.
    Nat Med. 2010 Feb;16(2):198-204 PMID: 20098431
  7. Occurrence of leukaemia following gene therapy of X-linked SCID.
    Nat Rev Cancer. 2003 Jul;3(7):477-88 PMID: 12835668
  8. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.
    Nat Immunol. 2006 Feb;7(2):207-15 PMID: 16369535
  9. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications.
    Nat Biotechnol. 2002 Jan;20(1):87-90 PMID: 11753368
  10. NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells.
    Cancer Res. 2009 Nov 15;69(22):8611-9 PMID: 19887607
  11. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.
    N Engl J Med. 2003 Jan 16;348(3):255-6 PMID: 12529469
  12. Regulation of CD27 expression on subsets of mature T-lymphocytes.
    J Immunol. 1993 Sep 1;151(5):2426-35 PMID: 7689607
  13. Bcl-2 overexpression enhances tumor-specific T-cell survival.
    Cancer Res. 2005 Mar 1;65(5):2001-8 PMID: 15753400
  14. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
    Science. 2003 Oct 17;302(5644):415-9 PMID: 14564000
  15. Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis.
    Mol Ther. 2009 Sep;17(9):1537-47 PMID: 19532134
  16. Murine leukemia induced by retroviral gene marking.
    Science. 2002 Apr 19;296(5567):497 PMID: 11964471
  17. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.
    Blood. 2005 Jun 1;105(11):4235-46 PMID: 15713797
  18. Focus on acute leukemias.
    Cancer Cell. 2002 Jun;1(5):417-20 PMID: 12124171
  19. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.
    J Clin Invest. 2008 Sep;118(9):3132-42 PMID: 18688285
  20. Fatal leukemia in interleukin-15 transgenic mice.
    Blood Cells Mol Dis. 2001 Jan-Feb;27(1):223-30 PMID: 11358383
  21. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
    Cell. 2006 Aug 25;126(4):663-76 PMID: 16904174
  22. Gene therapy targeting hematopoietic cells: better not leave it to chance.
    Acta Haematol. 2003;110(2-3):107-9 PMID: 14583670
  23. Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro.
    Nat Immunol. 2004 Apr;5(4):410-7 PMID: 15034575
  24. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment.
    Immunity. 1995 Oct;3(4):521-30 PMID: 7584142
  25. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.
    Immunity. 1998 Nov;9(5):669-76 PMID: 9846488
  26. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.
    J Clin Invest. 2008 Sep;118(9):3143-50 PMID: 18688286
  27. Rules for making human tumor cells.
    N Engl J Med. 2002 Nov 14;347(20):1593-603 PMID: 12432047
  28. Resistance of mature T cells to oncogene transformation.
    Blood. 2008 Sep 15;112(6):2278-86 PMID: 18566328
  29. A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.
    Mol Ther. 2002 Jun;5(6):788-97 PMID: 12027564
  30. Interleukin-2: inception, impact, and implications.
    Science. 1988 May 27;240(4856):1169-76 PMID: 3131876
  31. Spectratype/immunoscope analysis of the expressed TCR repertoire.
    Curr Protoc Immunol. 2001 May;Chapter 10:10.28.1-10.28.24 PMID: 18432693
  32. Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.
    Blood. 2000 Jul 15;96(2):467-74 PMID: 10887107
  33. An improved cyan fluorescent protein variant useful for FRET.
    Nat Biotechnol. 2004 Apr;22(4):445-9 PMID: 14990965
  34. Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene.
    Blood. 2007 Jun 15;109(12):5168-77 PMID: 17353346
  35. Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.
    J Immunother. 2004 Sep-Oct;27(5):405-18 PMID: 15314550
  36. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples.
    Hum Gene Ther. 2001 May 1;12(7):743-9 PMID: 11339891
  37. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
    Cell. 2007 Nov 30;131(5):861-72 PMID: 18035408
  38. Transcription start regions in the human genome are favored targets for MLV integration.
    Science. 2003 Jun 13;300(5626):1749-51 PMID: 12805549
  39. Gene therapy: therapeutic gene causing lymphoma.
    Nature. 2006 Apr 27;440(7088):1123 PMID: 16641981
Article Info
Journal
Molecular medicine (Cambridge, Mass.)
Abbr.
Mol Med
ISSN
1528-3658
Published
2011-00-00
Epub
2011-00-27
Pages
1223-32
Language
English
Region
England
NLM ID
9501023
PMCID
PMC3321800
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com